gbr 12935 has been researched along with amantadine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, I; Rehavi, M; Weizman, R | 1 |
| Hermans, E; Maloteaux, JM; Page, G; Peeters, M | 1 |
| Chemuturi, NV; Donovan, MD | 1 |
3 other study(ies) available for gbr 12935 and amantadine
| Article | Year |
|---|---|
Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter.
Topics: Amantadine; Animals; Benztropine; Carrier Proteins; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Piperazines; Rats; Reserpine | 1996 |
Increased dopamine uptake in striatal synaptosomes after treatment of rats with amantadine.
Topics: Amantadine; Animals; Binding, Competitive; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Male; Piperazines; Rats; Rats, Wistar; Synaptosomes; Tritium | 2000 |
Metabolism of dopamine by the nasal mucosa.
Topics: 2,4-Dinitrophenol; 3,4-Dihydroxyphenylacetic Acid; Amantadine; Animals; Biological Availability; Cattle; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Immunohistochemistry; Iproniazid; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nasal Mucosa; Organ Culture Techniques; Piperazines; Spectrophotometry, Ultraviolet | 2006 |